# Endogenous Galectin-8 protects against Th17 infiltration and fibrosis following acute kidney injury

**Authors:** Elisa Perez-Moreno, Adely de la Peña, Tomás Toledo, Javiera Saez, Francisca Pérez-Molina, Sofía Espinoza, Claudia Metz, Nicole Díaz-Valdivia, Lorena Azócar, Carolina Prado, Rodrigo Pacheco, Fabian Segovia-Miranda, Alejandro S. Godoy, Cristian A. Amador, Teo Feuerhake, Alfonso González, Andrea Soza

PMC · DOI: 10.1186/s10020-025-01245-y · Molecular Medicine · 2025-05-16

## TL;DR

This study shows that the protein Galectin-8 helps prevent kidney fibrosis and immune cell buildup after kidney injury.

## Contribution

The study reveals the endogenous protective role of Galectin-8 in preventing fibrosis and Th17 infiltration after acute kidney injury.

## Key findings

- Galectin-8 is crucial for preventing fibrosis by regulating extracellular matrix homeostasis.
- Lgals8−/− mice showed increased Th17 cell infiltration and collagen deposition in the fibrotic phase.
- Endogenous Gal-8 does not significantly affect acute kidney injury but prevents maladaptive repair.

## Abstract

Acute kidney injury (AKI) is a serious clinical condition characterized by a rapid decline in renal function, often progressing to chronic kidney disease (CKD) and fibrosis. The endogenous mechanisms influencing kidney injury resolution or maladaptive repair remain poorly understood. Galectin-8 (Gal-8), a tandem-repeat β-galactoside-binding lectin, plays a role in epithelial cell proliferation, epithelial-mesenchymal transition, and immune regulation, all of which are critical in AKI outcomes. While exogenous Gal-8 administration has shown renoprotective effects, its endogenous role in kidney injury progression and resolution remains unclear.

To investigate the endogenous role of Gal-8 in AKI, we compared the responses of Gal-8 knockout (Gal-8-KO; Lgals8−/− bearing a β-gal cassette under the Lgals8 gene promoter) and wild-type (Lgals8+/+) mice in a nephrotoxic folic acid (FA)-induced AKI model. Renal Gal-8 expression was assessed by β-galactosidase staining, lectin-marker colocalization, and RT-qPCR. Renal function, structure, and immune responses were evaluated at the acute (day 2) and fibrotic (day 14) phases of injury. Plasma creatinine levels were measured to assess renal function, while histological analyses evaluated tubular damage, renal inflammation, and extracellular matrix deposition. Flow cytometry was performed to characterize the immune response, focusing on pro-inflammatory T cells.

Galectin-8 was predominantly expressed in the renal cortex, localizing to tubules, glomeruli, and blood vessels, with its levels decreasing by half following AKI. Both Lgals8+/+ and Lgals8−/− mice exhibited similar renal function and structure impairments during the acute phase, though Lgals8+/+ mice showed slightly worse damage. By the fibrotic phase, Lgals8−/− mice exhibited more pronounced cortical damage and fibrosis, characterized by increased type I and III collagen deposition and enhanced Th17 cell infiltration, while myofibroblast activation remained comparable to that of Lgals8+/+ mice.

Endogenous Gal-8 does not significantly protect the kidney during the acute phase and is dispensable for cell proliferation and death in response to AKI. However, it is crucial in preventing maladaptive repair by regulating extracellular matrix homeostasis and mitigating fibrosis. Additionally, Gal-8 contributes to inflammation resolution by limiting persistent immune cell infiltration, particularly IL-17-secreting cells.

## Linked entities

- **Genes:** LGALS8 (galectin 8) [NCBI Gene 3964]
- **Proteins:** galectin-8 (galectin-8), IL17A (interleukin 17A)
- **Chemicals:** folic acid (PubChem CID 135398658)
- **Diseases:** acute kidney injury (MONDO:0002492), chronic kidney disease (MONDO:0005300)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Vim (vimentin) [NCBI Gene 22352], Cr1l (complement C3b/C4b receptor 1 like) [NCBI Gene 12946] {aka Crry, Mcp, mCRY}, Glb1 (galactosidase, beta 1) [NCBI Gene 12091] {aka Bge, Bgl, Bgl-e, Bgl-s, Bgl-t, Bgs}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 17386] {aka Clg, MMP-13, Mmp1}, Mcpt1 (mast cell protease 1) [NCBI Gene 17224] {aka Mcp-1}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Lgals9 (lectin, galactose binding, soluble 9) [NCBI Gene 16859] {aka LGALS35, Lgals5, gal-9, galectin-9}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Mmp8 (matrix metallopeptidase 8) [NCBI Gene 17394], Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Tcrb (T cell receptor beta chain) [NCBI Gene 21577] {aka TCRbeta, Tib}, Mmp14 (matrix metallopeptidase 14 (membrane-inserted)) [NCBI Gene 17387] {aka MMP-X1, MT-MMP-1, MT1-MMP, sabe}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Lgals3 (lectin, galactose binding, soluble 3) [NCBI Gene 16854] {aka GBP, L-34, Mac-2, gal3}, Havcr1 (hepatitis A virus cellular receptor 1) [NCBI Gene 171283] {aka KIM-1, TIM-1, Tim1, Timd1}, Mmp16 (matrix metallopeptidase 16) [NCBI Gene 17389] {aka MT-MMP 3, MT3-MMP, Mt3mmp}, pma (peroneal muscular atrophy) [NCBI Gene 18849], Cd8a (CD8 subunit alpha) [NCBI Gene 12525] {aka Ly-2, Ly-35, Ly-B, Lyt-2}, Lgals1 (lectin, galactose binding, soluble 1) [NCBI Gene 16852] {aka Gal-1, Galbp, L-14.5, L14, Lect14, galectin-1}, Lgals8 (lectin, galactose binding, soluble 8) [NCBI Gene 56048] {aka 1200015E08Rik, D13Ertd524e, Lgals-8}, Dnase1 (deoxyribonuclease I) [NCBI Gene 13419] {aka DNaseI, Dnl1}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, LGALS8 (galectin 8) [NCBI Gene 3964] {aka Gal-8, PCTA-1, PCTA1, Po66-CBP}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Lcn2 (lipocalin 2) [NCBI Gene 16819] {aka 24p3, NRL, Sip24}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Mmp3 (matrix metallopeptidase 3) [NCBI Gene 17392] {aka EMS-2, MMP-3, SL-1, SLN-1, SLN1, STR-1}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}
- **Diseases:** reperfusion injury (MESH:D015427), ureteral obstruction (MESH:D014517), MS (MESH:D009103), tubular damage (MESH:D000230), kidney failure (MESH:D051437), CKD (MESH:D051436), rheumatoid arthritis (MESH:D001172), Ischemia (MESH:D007511), decline in kidney function (MESH:D007680), systemic lupus erythematosus (MESH:D008180), demyelination (MESH:D003711), EAE (MESH:D004681), AKI (MESH:D058186), cortical damage (MESH:D054220), acute tubular injury (MESH:D001930), vascular rarefaction (MESH:D000073436), tissue damage (MESH:D017695), septic shock (MESH:D012772), sepsis (MESH:D018805), acute tubular damage (MESH:D000208), injury (MESH:D014947), glioblastoma (MESH:D005909), autoimmune and inflammatory conditions (MESH:D007249), fibrosis (MESH:D005355), Renal cortical damage (MESH:D007674), deaths (MESH:D003643), CRD (OMIM:120970), Tubular dilation (MESH:D002311), leucopenia (MESH:C536227), infections (MESH:D007239), heart failure (MESH:D006333), autoimmune uveitis (MESH:D014605), autoimmune disorders (MESH:D001327), collagen (MESH:D003095)
- **Chemicals:** paraffin (MESH:D010232), sialic acid (MESH:D019158), fucose (MESH:D005643), MMF (MESH:D009173), sodium bicarbonate (MESH:D017693), Alexa Fluor-568 (-), Hematoxylin (MESH:D006416), ionomycin (MESH:D015759), N-acetylgalactosamine (MESH:D000116), H&amp;E (MESH:D006371), Percoll (MESH:C016039), paraformaldehyde (MESH:C003043), poly-N-acetyl-lactosamine (MESH:C037199), Carbohydrate (MESH:D002241), formaldehyde (MESH:D005557), citrus pectin (MESH:C586814), luminal (MESH:D010634), brefeldin A (MESH:D020126), Alexa Fluor-647 (MESH:C569686), sucrose (MESH:D013395), salt (MESH:D012492), glycan (MESH:D011134), Creatinine (MESH:D003404), Trizol (MESH:C411644), FA (MESH:D005492), GlcNAc (MESH:D000117)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** MDCK — Canis lupus familiaris (Dog), Spontaneously immortalized cell line (CVCL_0422)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12083165/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12083165/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12083165/full.md

---
Source: https://tomesphere.com/paper/PMC12083165